Buhse LF - Search Results

1

Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.

Keire DA, Trehy ML, Reepmeyer JC, Kolinski RE, Ye W, Dunn J, Westenberger BJ, Buhse LF. Keire DA, et al. Among authors: buhse lf. J Pharm Biomed Anal. 2010 Mar 11;51(4):921-6. doi: 10.1016/j.jpba.2009.10.017. Epub 2009 Oct 30. J Pharm Biomed Anal. 2010. PMID: 19959313

2

Stable isotopic characterization of active pharmaceutical ingredients.

Jasper JP, Westenberger BJ, Spencer JA, Buhse LF, Nasr M. Jasper JP, et al. Among authors: buhse lf. J Pharm Biomed Anal. 2004 Apr 1;35(1):21-30. doi: 10.1016/S0731-7085(03)00581-8. J Pharm Biomed Anal. 2004. PMID: 15030876

3

Topical drug classification.

Buhse L, Kolinski R, Westenberger B, Wokovich A, Spencer J, Chen CW, Turujman S, Gautam-Basak M, Kang GJ, Kibbe A, Heintzelman B, Wolfgang E. Buhse L, et al. Int J Pharm. 2005 May 13;295(1-2):101-12. doi: 10.1016/j.ijpharm.2005.01.032. Int J Pharm. 2005. PMID: 15847995

4

Stable isotopic composition of the active pharmaceutical ingredient (API) naproxen.

Wokovich AM, Spencer JA, Westenberger BJ, Buhse LF, Jasper JP. Wokovich AM, et al. Among authors: buhse lf. J Pharm Biomed Anal. 2005 Jul 15;38(4):781-4. doi: 10.1016/j.jpba.2005.02.033. Epub 2005 Apr 14. J Pharm Biomed Anal. 2005. PMID: 15967309

5

Stability, dose uniformity, and palatability of three counterterrorism drugs-human subject and electronic tongue studies.

Sadrieh N, Brower J, Yu L, Doub W, Straughn A, Machado S, Pelsor F, Martin ES, Moore T, Reepmeyer J, Toler D, Nguyenpho A, Roberts R, Schuirmann DJ, Nasr M, Buhse L. Sadrieh N, et al. Pharm Res. 2005 Oct;22(10):1747-56. doi: 10.1007/s11095-005-6387-x. Epub 2005 Sep 22. Pharm Res. 2005. PMID: 16180133

6

Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques.

Westenberger BJ, Ellison CD, Fussner AS, Jenney S, Kolinski RE, Lipe TG, Lyon RC, Moore TW, Revelle LK, Smith AP, Spencer JA, Story KD, Toler DY, Wokovich AM, Buhse LF. Westenberger BJ, et al. Among authors: buhse lf. Int J Pharm. 2005 Dec 8;306(1-2):56-70. doi: 10.1016/j.ijpharm.2005.08.027. Epub 2005 Nov 2. Int J Pharm. 2005. PMID: 16266793

7

Effects of deaeration methods on dissolution testing in aqueous media: a study using a total dissolved gas pressure meter.

Gao Z, Moore TW, Doub WH, Westenberger BJ, Buhse LF. Gao Z, et al. Among authors: buhse lf. J Pharm Sci. 2006 Jul;95(7):1606-13. doi: 10.1002/jps.20622. J Pharm Sci. 2006. PMID: 16732563

8

Gauge repeatability and reproducibility for accessing variability during dissolution testing: a technical note.

Gao Z, Moore T, Smith AP, Doub W, Westenberger B, Buhse L. Gao Z, et al. AAPS PharmSciTech. 2007 Oct 12;8(4):E82. doi: 10.1208/pt0804082. AAPS PharmSciTech. 2007. PMID: 18181543 Free PMC article.

9

Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.

Ritschel WA, Ye W, Buhse L, Reepmeyer JC. Ritschel WA, et al. Int J Pharm. 2008 Oct 1;362(1-2):67-73. doi: 10.1016/j.ijpharm.2008.06.016. Epub 2008 Jun 26. Int J Pharm. 2008. PMID: 18634862

10

Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.

Tami C, Puig M, Reepmeyer JC, Ye H, D'Avignon DA, Buhse L, Verthelyi D. Tami C, et al. Biomaterials. 2008 Dec;29(36):4808-14. doi: 10.1016/j.biomaterials.2008.08.024. Epub 2008 Sep 17. Biomaterials. 2008. PMID: 18801571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page